Financial Snapshot

Revenue
$40.09M
TTM
Gross Margin
17.32%
TTM
Net Earnings
-$6.635M
TTM
Current Assets
$22.84M
Q4 2019
Current Liabilities
$14.25M
Q4 2019
Current Ratio
160.2%
Q4 2019
Total Assets
$24.07M
Q4 2019
Total Liabilities
$14.38M
Q4 2019
Book Value
$9.685M
Q4 2019
Cash
$7.970K
Q4 2019
P/E
-0.02128
Apr 21, 2023 EST
Free Cash Flow
$183.1K
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $141.19 Thousand

About KIWA BIO-TECH PRODUCTS GROUP CORP

Kiwa Bio-Tech Products Group Corp. engages in the development, manufacture and distribution of environmentally safe bio-technological products for agriculture. The company is headquartered in Ontario, California and currently employs 16 full-time employees. The company went IPO on 2002-02-12. The firm operates primarily in the mainland China. The firm's products include biological organic fertilizer series, compound microbial fertilizer series, biological water-soluble fertilizer series, microorganism bacterium agent series and biological soil remediation series. Its biological organic fertilizer series include Bio-organic Fertilizer (50 million Bacteria/g), Bio-organic Fertilizer (200 million Bacteria/g) and Bio-organic Fertilizer (1 billion Bacteria/g). Its compound microbial fertilizer series include specialized fertilizers for fruit trees, tea trees, Chinese herbs, flowers, vegetables, tobacco and all crops. Its biological water-soluble fertilizer series includes Yimuling Water-soluble Biofertilizer. Its microorganism bacterium agent series include Microorganism Bacterium Agent, Difukang-Agricultural Microbial Inoculum and others.

Industry: Agricultural Chemicals Peers: Cell Source, Inc. GENEREX BIOTECHNOLOGY CORP